OCUFLOX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ocuflox, and when can generic versions of Ocuflox launch?
Ocuflox is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in OCUFLOX is ofloxacin. There are seventy-eight drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the ofloxacin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ocuflox
A generic version of OCUFLOX was approved as ofloxacin by LARKEN LABS on September 2nd, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OCUFLOX?
- What are the global sales for OCUFLOX?
- What is Average Wholesale Price for OCUFLOX?
Summary for OCUFLOX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 167 |
Clinical Trials: | 3 |
Patent Applications: | 4,180 |
Drug Prices: | Drug price information for OCUFLOX |
What excipients (inactive ingredients) are in OCUFLOX? | OCUFLOX excipients list |
DailyMed Link: | OCUFLOX at DailyMed |
Recent Clinical Trials for OCUFLOX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Montefiore Medical Center | Phase 3 |
Winston Chamberlain, MD, PhD | Phase 4 |
Stanford University | Phase 4 |
Pharmacology for OCUFLOX
Drug Class | Quinolone Antimicrobial |
US Patents and Regulatory Information for OCUFLOX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | OCUFLOX | ofloxacin | SOLUTION/DROPS;OPHTHALMIC | 019921-001 | Jul 30, 1993 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OCUFLOX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | OCUFLOX | ofloxacin | SOLUTION/DROPS;OPHTHALMIC | 019921-001 | Jul 30, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | OCUFLOX | ofloxacin | SOLUTION/DROPS;OPHTHALMIC | 019921-001 | Jul 30, 1993 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OCUFLOX
See the table below for patents covering OCUFLOX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 505116 | ⤷ Sign Up | |
Finland | 71155 | ⤷ Sign Up | |
New Zealand | 198224 | 9-HALO-7-OXO-2,3-DIHYDRO-7H-PYRIDO(1,2,3,-DE)(1,4)BENZOXAZINE-6-CARBOXYLIC ACID DERIVATIVES | ⤷ Sign Up |
Yugoslavia | 42422 | ⤷ Sign Up | |
South Africa | 8105604 | ⤷ Sign Up | |
Spain | 8604018 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for OCUFLOX
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1429780 | 132013902137451 | Italy | ⤷ Sign Up | PRODUCT NAME: CIPROFLOXACINA E DESAMETASONE(CILODEX); AUTHORISATION NUMBER(S) AND DATE(S): 48976, 20120810;041182015/M, 20121106 |
0206283 | C980016 | Netherlands | ⤷ Sign Up | PRODUCT NAME: LEVOFLOXACINE, DESGEWENST IN DE VORM VAN EEN SOLVAAT, IN HET BIJZONDER LEVOFLOXACINE-HEMIHYDRAAT; NAT. REGISTRATION NO/DATE: RVG 21810 - RVG 21812 19971209; FIRST REGISTRATION: GB 13402/0011 - 13402/0013 19970606 |
1429780 | SPC/GB12/058 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003 |
1429780 | 122012000070 | Germany | ⤷ Sign Up | PRODUCT NAME: KOMBINATION AUS CIPROFLOXACIN UND DEXAMETHASON, INSBESONDERE CIPROFLOXACINHYDROCHLORID UND DEXAMETHASON; NAT. REGISTRATION NO/DATE: 85150.00. 00 20120830; FIRST REGISTRATION: DAENEMARK 48976 20120808 |
0206283 | 98C0041 | Belgium | ⤷ Sign Up | PRODUCT NAME: LEVOFLOXACINUM HEMIHYDRICUM; NAT. REGISTRATION NO/DATE: 354 IS 370 F3 19980624; FIRST REGISTRATION: GB 134020011 19970606 |
0206283 | SPC/GB97/085 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: LEVOFLOXACIN, OPTIONALLY IN THE FORM OF A HEMIHYDRATE; REGISTERED: UK 13402/0011 19970606; UK 13402/0012 19970606; UK 13402/0013 19970606 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |